Skip to content

Gain the Decision Advantage

Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.

Register Now
  • About Us
    • Who We Are
    • Leadership
    • Corporate Citizenship
    • Partners
    • Contact Us
  • Customer Login
  • LifeSphere

    • MultiVigilance

    • Advanced Intake

    • Literature Intelligence

    • ReporterX

    • Advanced Signals

    • Business Intelligence

    • Document Distribution

    • Advanced Compliance Docs

    • RIM

    • Product Compliance

    • Documents

    • Submissions

    • Labeling

    • Regulatory Analytics

    • Health Authority Interactions

    • Regulatory Intelligence

    • Medical Information

    • ReporterX

    • Product Complaints

    • Quality Management System

    • Quality Documents

    • Safety
      • MultiVigilance
      • Advanced Intake
      • Literature Intelligence
      • Advanced Compliance Docs
      • Business Intelligence
      • Reporter
      • Unified, AI-Assisted Patient Data Collection, powered by NavaX
    • Regulatory
      • RIM
      • Product Compliance
      • Documents
      • Submissions
      • Labeling
      • Regulatory Analytics
      • Health Authority Interactions
      • Intelligence
    • Medical Affairs
      • Medical Information
      • Reporter
    • Quality
      • Quality Management System
      • Quality Documents
  • NavaX
    • NavaX for Safety
      • MedDRA Coding Agent
      • Distribution Agents
      • Signals Agents
      • ReporterX
      • Advanced Intake
      • Literature Intelligence
      • Advanced Signals
      • Translation
    • NavaX for Regulatory
      • Intelligence Agents
      • Health Authority Interactions
      • Regulatory Intelligence
    • NavaX Agents
      • MedDRA Coding Agent
      • Signals Agents
      • Distribution Agents
      • Intelligence Agents
  • XDI
  • SPORIFY
  • Resources
    • Webinars
    • Case Studies
    • Resources Library
    • Consulting
  • Who We Serve
    • Customers
    • Enterprise
    • Small to Medium Pharma
    • CROs
  • News
    • Breakthrough 2027
    • Events & Webinars
    • Media
    • Blogs & Articles
    • Podcasts
  • Book a Demo
  • LifeSphere
    • Safety
      • MultiVigilance
      • Advanced Intake
      • Literature Intelligence
      • Advanced Compliance Docs
      • Advanced Signals
      • Business Intelligence
      • Document Distribution
      • Reporter
      • Translation
    • Regulatory
      • RIM
      • Product Compliance
      • Documents
      • Submissions
      • Labeling
      • Regulatory Analytics
      • Health Authority Interactions
      • Regulatory Intelligence
    • Medical Affairs
      • Medical Information
      • Reporter
    • Quality
      • Quality Management System
      • Quality Document Management System
  • NavaX
    • NavaX for Safety
      • Advanced Intake
      • Advanced Signals
      • Literature Intelligence
    • NavaX for Regulatory
      • Health Authority Interactions
      • Regulatory Intelligence
    • NavaX Agents
  • XDI
  • SPORIFY
  • Resources
    • Resources Library
    • Consulting
  • Who We Serve
    • Customers
    • Enterprise
    • Small to Medium Pharma
    • CROs
  • News
    • Events & Webinars
    • Media
    • Blog
  • Book a Demo
  • About Us
    • Who We Are
    • Leadership
    • Corporate Citizenship
    • Contact Us
  • Customer login
  • LifeSphere
    • Safety
      • MultiVigilance
      • Advanced Intake
      • Literature Intelligence
      • Advanced Compliance Docs
      • Advanced Signals
      • Business Intelligence
      • Document Distribution
      • Reporter
      • Translation
    • Regulatory
      • RIM
      • Product Compliance
      • Documents
      • Submissions
      • Labeling
      • Regulatory Analytics
      • Health Authority Interactions
      • Regulatory Intelligence
    • Medical Affairs
      • Medical Information
      • Reporter
    • Quality
      • Quality Management System
      • Quality Document Management System
  • NavaX
    • NavaX for Safety
      • Advanced Intake
      • Advanced Signals
      • Literature Intelligence
    • NavaX for Regulatory
      • Health Authority Interactions
      • Regulatory Intelligence
    • NavaX Agents
  • XDI
  • SPORIFY
  • Resources
    • Resources Library
    • Consulting
  • Who We Serve
    • Customers
    • Enterprise
    • Small to Medium Pharma
    • CROs
  • News
    • Events & Webinars
    • Media
    • Blog
  • Book a Demo
  • About Us
    • Who We Are
    • Leadership
    • Corporate Citizenship
    • Contact Us
  • Customer login

The Future of Patient Safety: A Fireside Chat with AstraZenca
Mladen Prenc2021-11-19T10:59:44+00:00

Share This on LinkedIn

LinkedIn

Related Posts

From Growth to Global Scale: Building a Regulatory Foundation for the Future

From Growth to Global Scale: Building a Regulatory Foundation for the Future

November 3, 2026
The AI-Powered Safety Organization: Transforming PV Beyond Case Intake

The AI-Powered Safety Organization: Transforming PV Beyond Case Intake

November 3, 2026
Operationalizing AI Across the PV Lifecycle Towards Real ROI

Operationalizing AI Across the PV Lifecycle Towards Real ROI

September 25, 2026
Webinar: Driving Cross-Domain R&D Insights with Meaning-Aware AI

Webinar: Driving Cross-Domain R&D Insights with Meaning-Aware AI

August 18, 2026

ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.

Quick Links

  • Home
  • Schedule a Demo
  • Careers
  • Privacy Policy
  • AI Trust Center
  • POSH Policy
  • Speak Up!
  • Contact Us

Follow Us

© 2026 ArisGlobal – All Rights Reserved

Page load link
Font resize
Contrast
Accessibility by WAH